Evidence map›Paper›PMID 41976378›Full record

ArticleCancers2026

Impact of Time of Administration, Fasting, and a Low-Carbohydrate Diet on Alpelisib-Associated Hyperglycemia and Efficacy: A Pilot Randomized Controlled Phase IIb Trial.

Eduard Vrdoljak, Marija Pancirov, Josipa Flam, Dora Čerina Pavlinović, Matea Jakas Vučić, Marica Barać, Natalija Dedić Plavetić, Paula Podolski, Mladen Krnić, Žarko Bajić

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eduard VrdoljakDepartment of Oncology, University Hospital Center Split, Spinčićeva ul. 5, 21000 Split, Croatia.
Marija PancirovOrdinacija za Bolesti Dojke, Ordinacija dr. Vedrana Buljević, Spinčićeva 2, 21000 Split, Croatia.
Josipa FlamDepartment of Radiotherapy and Oncology, University Hospital Center Osijek, Ul. Josipa Huttlera 4, 31000 Osijek, Croatia.
Dora Čerina PavlinovićDepartment of Oncology, University Hospital Center Split, Spinčićeva ul. 5, 21000 Split, Croatia.
Matea Jakas VučićDepartment of Oncology, University Hospital Center Split, Spinčićeva ul. 5, 21000 Split, Croatia.
Marica BaraćDepartment of Oncology, University Hospital Center Split, Spinčićeva ul. 5, 21000 Split, Croatia.
Natalija Dedić PlavetićDepartment of Oncology, University Hospital Center Zagreb, Ulica Mije Kišpatića 12, 10000 Zagreb, Croatia.ORCID 0000-0003-0505-4756
Paula PodolskiDepartment of Oncology, University Hospital Center Zagreb, Ulica Mije Kišpatića 12, 10000 Zagreb, Croatia.ORCID 0000-0002-9922-1086
Mladen KrnićSchool of Medicine, University of Split, Šoltanska ul. 2, 21000 Split, Croatia.ORCID 0000-0002-3676-1608
Žarko BajićResearch Unit "Dr. Mirko Grmek", Psychiatric Clinic Sveti Ivan, Jankomir 11, 10090 Zagreb, Croatia.ORCID 0000-0002-7983-6892

Funding

Novartis EudraCT 2021-000845-42
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alpelisibbreast cancerbreast neoplasmsdietfulvestrantglucosehyperglycemiaPIK3CA mutation

Identifiers

PMID41976378
PMCPMC13072385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.